DK163960C - Anvendelse af 4-((alfa-metyl)-2,3-dimetylbenzyl)-imidazol til fremstilling af veterinaere praeparater - Google Patents

Anvendelse af 4-((alfa-metyl)-2,3-dimetylbenzyl)-imidazol til fremstilling af veterinaere praeparater

Info

Publication number
DK163960C
DK163960C DK508985A DK508985A DK163960C DK 163960 C DK163960 C DK 163960C DK 508985 A DK508985 A DK 508985A DK 508985 A DK508985 A DK 508985A DK 163960 C DK163960 C DK 163960C
Authority
DK
Denmark
Prior art keywords
imidazole
methyl
dimethylbenzyl
alfa
preparation
Prior art date
Application number
DK508985A
Other languages
Danish (da)
English (en)
Other versions
DK163960B (da
DK508985D0 (da
DK508985A (da
Inventor
Raimo Einari Virtanen
Arto Johannes Karjalainen
Kauko Oiva Antero Kurkela
Antti Tapani Vaehae-Vahe
Outi Maritta Vainio-Kivinen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of DK508985D0 publication Critical patent/DK508985D0/da
Publication of DK508985A publication Critical patent/DK508985A/da
Publication of DK163960B publication Critical patent/DK163960B/da
Application granted granted Critical
Publication of DK163960C publication Critical patent/DK163960C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Stringed Musical Instruments (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Photoreceptors In Electrophotography (AREA)
DK508985A 1984-12-04 1985-11-05 Anvendelse af 4-((alfa-metyl)-2,3-dimetylbenzyl)-imidazol til fremstilling af veterinaere praeparater DK163960C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI844786A FI844786A0 (fi) 1984-12-04 1984-12-04 Terapeutiskt utnyttjbar foerening.
FI844786 1984-12-04

Publications (4)

Publication Number Publication Date
DK508985D0 DK508985D0 (da) 1985-11-05
DK508985A DK508985A (da) 1986-06-05
DK163960B DK163960B (da) 1992-04-27
DK163960C true DK163960C (da) 1992-09-21

Family

ID=8520010

Family Applications (1)

Application Number Title Priority Date Filing Date
DK508985A DK163960C (da) 1984-12-04 1985-11-05 Anvendelse af 4-((alfa-metyl)-2,3-dimetylbenzyl)-imidazol til fremstilling af veterinaere praeparater

Country Status (11)

Country Link
US (1) US4670455A (cs)
EP (1) EP0187471B1 (cs)
JP (1) JPS61134314A (cs)
AT (1) ATE65694T1 (cs)
AU (1) AU572364B2 (cs)
DE (1) DE3583670D1 (cs)
DK (1) DK163960C (cs)
FI (1) FI844786A0 (cs)
IE (1) IE58269B1 (cs)
NZ (1) NZ213604A (cs)
ZA (1) ZA858416B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
GB2206880B (en) 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
GB2215206B (en) 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
AR015744A1 (es) * 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
WO2010065547A1 (en) * 2008-12-01 2010-06-10 Map Pharmaceuticals, Inc. Inhalation delivery methods and devices
WO2010074753A1 (en) * 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
WO2013069025A1 (en) 2011-11-11 2013-05-16 Neon Laboratories Ltd. "process for the preparation of dexmedetomidine"
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
ES2856189T3 (es) 2013-10-07 2021-09-27 Teikoku Pharma Usa Inc Métodos y composiciones para el tratamiento del trastorno de hiperactividad por déficit de atención, ansiedad e insomnio utilizando composiciones transdérmicas de dexmedetomidina
TWI704933B (zh) 2013-10-07 2020-09-21 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法
BR112016006848A2 (pt) 2013-10-07 2017-08-01 Teikoku Pharma Usa Inc métodos e composições para distribuição transdérmica de uma quantidade não sedativa de dexmedetomidina
US9717796B1 (en) 2016-04-20 2017-08-01 Slypharma, Llc Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
EP3562486B1 (en) 2016-12-31 2024-03-13 Bioxcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
MX2020014000A (es) 2018-06-27 2021-06-15 Bioxcel Therapeutics Inc Formulaciones en lámina que contienen dexmedetomidina y métodos para producirlas.
US11160791B2 (en) 2018-11-01 2021-11-02 Medefil, Inc. Dexmedetomidine injection premix formulation in ready to use (RTU) bags
CA3145388A1 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2096987B (en) * 1981-04-22 1984-04-04 Farmos Oy Substituted imidazole and imidazole derivatives and their preparation and use
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
DE3378118D1 (en) * 1982-08-14 1988-11-03 Wellcome Found Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations

Also Published As

Publication number Publication date
JPH0465050B2 (cs) 1992-10-16
AU4997185A (en) 1986-06-12
IE853024L (en) 1986-06-04
JPS61134314A (ja) 1986-06-21
AU572364B2 (en) 1988-05-05
IE58269B1 (en) 1993-08-25
FI844786A0 (fi) 1984-12-04
DK163960B (da) 1992-04-27
ATE65694T1 (de) 1991-08-15
EP0187471A2 (en) 1986-07-16
US4670455A (en) 1987-06-02
DE3583670D1 (de) 1991-09-05
ZA858416B (en) 1986-07-30
DK508985D0 (da) 1985-11-05
DK508985A (da) 1986-06-05
EP0187471A3 (en) 1988-09-14
NZ213604A (en) 1988-09-29
EP0187471B1 (en) 1991-07-31

Similar Documents

Publication Publication Date Title
DK163960C (da) Anvendelse af 4-((alfa-metyl)-2,3-dimetylbenzyl)-imidazol til fremstilling af veterinaere praeparater
TR199801350T2 (xx) Yeni sikloalkil ikameli imidazoller.
YU6393A (sh) Novi derivati amidina i njihovo dobijanje
DE69724246D1 (de) Neue substituierte imidazolverbindungen
DK46489A (da) Anvendelse af 4-(1-(2,3-dimetylfenyl)-aetyl)-1h-imidazol til fremstilling af laegemidler til perioperativ anvendelse
IE790107L (en) Substituted propanolamine and morpholine derivatives
MX9301783A (es) Derivados de 1-[2-arilsulfonilamino)-etil-1-oxo]-piperidina, su preparacion y su aplicacion en terapeutica.
YU47204B (sh) Derivati didehidro-vitamina d3
DZ613A1 (fr) Nouveaux dérivés de l'éthanol, leur préparation etleur utilisation comme fongicides.
NL350005I1 (nl) Imidazoolverbindingen en biocidepreparaten, die deze bevatten.
NL193283B (nl) 4,4-Dialkyl-1-[4-[4-(2-pirimidinyl)-1-piperazinyl]-butyl]-2,6- piperazinedionen.
IS1565B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
ES513228A0 (es) Un procedimiento para la preparacion de una composicion de derivados del imidazol.
FI91964C (fi) Menetelmä uusien, farmaseuttisesti aktiivisten 1-(hydroksistyryyli)-5H-2,3-bentsodiatsepiinijohdannaisten valmistamiseksi
FI821316A7 (fi) Menetelmä uusien substituoitujen imidatsoli- ja imidatsoliinijohdannaisten valmistamiseksi.
NL194463B (nl) Farmaceutisch preparaat dat 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H- imidazool-1-yl)methyl]-4H-carbazool-4-on bevat.
ES2159857T3 (es) Derivados del 1-((tien-2-il)metil)-imidazol con una actividad agonista respecto al adrenoreceptor alfa2.
DK175683D0 (da) Fungicidt middel
DK157134C (da) Analogifremgangsmaade til fremstilling af 1-(5-chlorpyrid-2-yl)-1-(2,4-dihalogenphenyl)-2-(1,2,4-triazol-1-yl)-ethanol-forbindelser eller deres farmaceutisk acceptable syreadditionssalte
MA19793A1 (fr) Procede de preparation de 1 - ( 1,3 - dioxolanne -2-yl "methyl) -1 h - imidazoles et -1h-1,2,4- triazoles utilisables en therapeutique .
DK0591236T3 (da) Fremgangsmåde til fremstilling af 5-(3-butyryl-2,4,6-trimethyl)-2-(1-(ethoxyimino)propyl)-3-hydroxycyklohex-2-en-1-on
FI880987A0 (fi) 1-(1-aryl-2-hydroxietyl) imidazoler och deras salter, foerfarande foer deras framstaellning, laekemedel innehaollande dessa foereningar och deras anvaendning.
SE430117B (sv) Fungicid beredning innehallande 1-(beta-(allyloxi)-2,4-diklorofenetyl) imidazol och en pyrimidinmetanol
DE3874361D1 (de) Als analgetika verwendbare 1-((4-morpholinyl)alkyl)-1h-indole und deren herstellung.
DK556384D0 (da) Anvendelse af 1-(2,4-dichlorphenyl)-1-(4-chlorbenzylmercapto)-2-(1,2,4-triazol-1-yl)-ethan til regulering af plantevaekst

Legal Events

Date Code Title Description
PUP Patent expired